Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

Severe acute respiratory syndrome (SARS) is an infectious disease caused by a newly identified human coronavirus (SARS-CoV). Currently, no effective drug exists to treat SARS-CoV infection. In this study, we investigated whether a panel of commercially available antiviral drugs exhibit in vitro anti...

Full description

Bibliographic Details
Main Authors: Emily L.C. Tan, Eng Eong Ooi, Chin-Yo Lin, Hwee Cheng Tan, Ai Ee Ling, Bing Lim, Lawrence W. Stanton
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2004-04-01
Series:Emerging Infectious Diseases
Subjects:
In vitro
antivirals
agents
antiviral
antiviral agents
antiviral drugs
Online Access:https://wwwnc.cdc.gov/eid/article/10/4/03-0458_article

Internet

https://wwwnc.cdc.gov/eid/article/10/4/03-0458_article

Similar Items